Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants

BACKGROUND: Pre-exposure prophylaxis (PrEP) is a novel HIV prevention method whereby HIV-negative individuals take the drugs tenofovir and emtricitabine to prevent HIV acquisition. Optimal adherence is critical for PrEP efficacy. Chemsex describes sexual activity under the influence of psychoactive...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Halloran, Charlotte, Rice, Brian, White, Ellen, Desai, Monica, Dunn, David T, McCormack, Sheena, Sullivan, Ann K., White, David, McOwan, Alan, Gafos, Mitzy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913514/
https://www.ncbi.nlm.nih.gov/pubmed/31739177
http://dx.doi.org/10.1016/j.drugpo.2019.10.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913514/
https://www.ncbi.nlm.nih.gov/pubmed/31739177
http://dx.doi.org/10.1016/j.drugpo.2019.10.007

Ejemplares similares